Science Explorer Interactive view Map
Company · Vancouver · Canada

Celator Pharmaceuticals (Canada)

Research works
47
▼ 99% vs 2013–17
Citations
2.4k
51.8 per fractional work
Top-10% rate
0.0%
record average 16.5%
Open access
20%
world 28%

Not ranked overall: Celator Pharmaceuticals (Canada) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Which keywords describe research at Celator Pharmaceuticals (Canada)?

By fractional works in all years, weighted toward what it does more of than the world: Nanoparticles, Tumor Targeting, Cancer Therapy, Biomedical Applications, Drug Delivery, Nanocarriers, Surface Engineering and Prognostic Factors.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Nanoparticles14▲ 23×7 topics
  2. Tumor Targeting11▲ 171×3 topics
  3. Cancer Therapy10▲ 35×4 topics
  4. Biomedical Applications10▲ 20×4 topics
  5. Drug Delivery10▲ 43×2 topics
  6. Nanocarriers9▲ 453×1 topic
  7. Surface Engineering9▲ 173×1 topic
  8. Prognostic Factors6▲ 28×4 topics
  9. Gene Therapy4▲ 31×3 topics
  10. Chemotherapy4▲ 10×4 topics
  11. RNA Interference3▲ 65×1 topic
  12. siRNA Delivery3▲ 96×1 topic
  13. Hematopoietic Stem Cells3▲ 62×2 topics
  14. Self-Assembly3▲ 16×4 topics
  15. Genomic Stability3▲ 64×2 topics
  16. Biosensors3▲ 10×2 topics
  17. Immunotherapy3▲ 8.8×5 topics
  18. AML3▲ 117×1 topic
  19. Acute Myeloid Leukemia3▲ 117×1 topic
  20. DNA nanotechnology3▲ 55×1 topic
  21. Membrane Proteins3▲ 30×2 topics
  22. aptamers3▲ 55×1 topic
  23. DNA2▲ 160×1 topic
  24. Topoisomerases2▲ 160×1 topic
  25. Acute Lymphoblastic Leukemia2▲ 121×1 topic
  26. Childhood Cancer2▲ 121×1 topic
  27. Ion Channels2▲ 14×3 topics
  28. Chemotherapy-Induced Peripheral Neuropathy1▲ 58×1 topic
  29. Lipid Rafts1▲ 41×1 topic
  30. Membrane Lipids1▲ 49×1 topic
  31. Photodynamic Therapy1▲ 19×2 topics
  32. Taxanes1▲ 58×1 topic
  33. Calcium Channels1▲ 36×1 topic
  34. Reactive Oxygen Species1▲ 5.7×3 topics
  35. Voltage-Gated Channels1▲ 36×1 topic
  36. Fluorescence Imaging1▲ 21×1 topic
  37. Photothermal Therapy1▲ 28×1 topic
  38. Targeted Therapy1▲ 11×3 topics
  39. Therapeutic Targets1▲ 10×2 topics
  40. ATP-dependent Transporters1▲ 42×1 topic

Which research topics does Celator Pharmaceuticals (Canada) publish most on?

By volume in 2022–2025: Dermatology and Skin Diseases, Economic Growth and Development, Copyright and Intellectual Property and Cybercrime and Law Enforcement Studies.

  1. 1 Dermatology and Skin Diseases Dermatology 0 works
  2. 2 Economic Growth and Development Information Systems 0 works
  3. 3 Copyright and Intellectual Property Marketing 0 works
  4. 4 Cybercrime and Law Enforcement Studies Information Systems 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available20.0%not open80.0%

World: 28% of research is openly available.

with international co-authors29.5%domestic only70.5%

World: 19% is written across borders.

How has Celator Pharmaceuticals (Canada)'s research output changed?

Output in 2018–2022 was 99% lower than in 2013–2017.

19952000200520102015
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Vancouver

All research institutions in Vancouver

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.